Company intelligence / Profile preview

Smisson-Cartledge Biomedical

Macon, Georgia, United States

Ownership: Private
Development stage: Other

Overview

Smisson-Cartledge Biomedical LLC develops and commercializes the ThermaCor 1200 Rapid Infusion System, a portable, rugged, and easy-to-use medical device for rapid, temperature-controlled fluid and blood product infusion. It is designed for use in a wide range of surgical and emergency settings, with a focus on rapid, safe delivery of warmed fluids, including crystalloids, colloids, and packed red blood cells, and is suitable for both adult and pediatric patients.

Therapeutic areas: CardiovascularImmunologyWomen's HealthOtherMen's HealthOncology
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Exergen Global (temperature sensing technology)

Beyond the preview

Go deeper on Smisson-Cartledge Biomedical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Smisson-Cartledge Biomedical.

Explore the full profile